CoChat

Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis

Levy, Cynthia, Martin, Eric · 2017 · Seminars in Liver Disease

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Primary sclerosing cholangitis (PSC) is a chronic, immune-mediated cholestatic liver disease that often progresses to secondary biliary cirrhosis and end-stage liver disease. Short of liver transplantation (LT), there is no effective treatment for PSC. PSC accounts for approximately 5% of total adult LTs in the US and is currently the fifth most common indication for LT. Patient and graft survival for PSC is among the highest for all indications for LT. The main factors that impact outcomes after LT for PSC include biliary strictures, rejection, and recurrence of PSC. Recurrent PSC (rPSC) develops in 20% of LT recipients within 5 years of LT and is associated with negative patient and graft survival. LT is a viable option for recipients who develop rPSC and progress to graft failure.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-0037-1608655

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 100 · Cited by 46

Metadata

Authors
Levy, C., & Martin, E.
Affiliations
University of Miami (US)
Venue
Seminars in Liver Disease
Published
2017-11
Volume
37
Issue
04
Pages
305-313
ISSN
  • 0272-8087 (ISSN-L)
  • 1098-8971
OpenAlex
W2781003852
Cited by
46
References
100
Citations by year
2026: 4 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 5
FWCI
2.19
Type
journal article
Language
en
Open access
closed
Locations
  • Seminars in Liver Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary sclerosing cholangitis, liver transplantation, biliary strictures, graft rejection, graft survival, patient survival, end-stage liver disease, biliary cirrhosis
MeSH terms
Graft Rejection, Graft Survival, Humans, Recurrence, Risk Factors, Time Factors, Tissue Donors, Waiting Lists, Cholangitis, Sclerosing, Liver Transplantation, Treatment Outcome, Disease Progression, End Stage Liver Disease, Time-to-Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis. https://app.cochat.ai/papers/10.1055/s-0037-1608655
The paper
Levy, C., & Martin, E. (2017). Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis. Seminars in Liver Disease. https://doi.org/10.1055/s-0037-1608655

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.